ABSTRACT Three monoclonal antibodies against human monocytes have been produced by somatic cell fusion. Extensive specificity analysis suggests that these antibodies react with most if not all human peripheral blood monocytes and not with highly purified T or B cells. Initial chemical characterization of the monocyte antigen recognized by two of these antibodies is presented. The molecule is a single polypeptide chain with an apparent molecular weight of 200,000. These reagents should prove useful in the clinical definition of disorders of monocyte differentiation, in studies of monocyte function, and in the elucidation of the genetics and structure of monocyte cell surface antigens.
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It is apparent that the macrophage participates in virtually all phases of the immune response (1) . To some extent the controversy about the many roles ascribed to cells of the macrophage-monocyte lineage derives from the difficulty encountered in attempts to define this cell morphologically, functionally, or antigenically (2-6). There is general agreement that a cell that is mononuclear, that phagocytoses via an Fc receptor, and that, at the same time, produces lysozyme is a macrophage. Although this definition is useful, it is difficult to utilize such criteria for either the isolation of monocytes or for the elimination of these cells from other cellular populations (7) (8) (9) .
Antigenic analysis of macrophages has been exceedingly complicated although much progress has been made. Heteroantisera to pooled populations of murine and human macrophages have been produced (10) (11) (12) and recently Springer et al. (13) described a murine macrophage differentiation antigen, termed Mac-i, by utilizing a monoclonal antibody. Similar studies in man have been limited, although Breard et al. (14) recently described a monoclonal antibody reactive with human peripheral blood monocytes.
In this report, we describe the production of three monoclonal antibodies against human monocytes. Their initial characterization suggests their potential utility in defining both the structure of monocyte differentiation antigens and the relationship between monocytes and other cell populations.
MATERIALS AND METHODS Immunization Eight-week-old BALB/c mice were immunized with human peripheral blood monocytes obtained from a single healthy donor. Mononuclear cells purified by centrifugation on Ficoll/Hypaque were plated in plastic dishes for 15 hr at 370C.
The adherent cells were subsequently harvested and immediately injected into mice. Each mouse received two intraperitoneal injections of 107 cells, 3 weeks apart. Four days after the second injection, mice were sacrificed and their spleens were removed and used for fusion.
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Cell fusion and cloning of hybrids Two separate fusions were performed between spleen cells and the nonsecreting cell line Sp2/0-Agl4 (15) by the method of Kennett et al. (16) with slight modifications (17) . Supernatants were tested on various cell panels, and those considered to be monocyte specific were cloned by growth at limiting dilution.
Preparation of cells for assays Normal Human Cells. These were fractionated by the following procedures. Heparinized venous blood was diluted with an equal volume of RPMI-1640 medium before centrifugation on Ficoll/Hypaque (18) . The buffy coat containing the mononuclear cells was collected, washed twice with RPMI-1640, and resuspended in 20% serum enriched medium.
Monocytes. Peripheral blood mononuclear cells (20 X 106 in 25 ml of RPMI/20% serum) were placed in 100 X 20 mm plastic dishes and incubated overnight at 37"C in a humid atmosphere of 5% C02/95% air. The nonadherent cells were removed by repeatedly washing the dishes with warm RPMI-1640 medium. The adherent cells were released by gently scraping the surface with a sterile rubber policeman. Such cells were >95% viable by trypan blue exclusion, and 70-90% of them were characteristic of monocytes when stained with euchrysine (19) .
T lymphocytes. Purified T cells were obtained by passage of nonadherent cells through nylon wool (20) . Briefly, [5] [6] X 107 cells in 0.5 ml of RPMI/5% serum were incubated in a plastic straw loaded with nylon wool (Fenwal Laboratories, Deerfield, IL) for 45 min at 370C. T lymphocytes were eluted from the straws by using 10 Cytotoxicity Tests. None of the supernatants of the cell hybrids tested was cytotoxic in a direct cytotoxicity assay. However, when tested with the aid of a rabbit anti-mouse IgG reagent, supernatants 61D3, 63D2, and 63D3 killed over 80% of the adherent cell population, not only from the donor used in the immunization but also from another donor (Table 3) .
Binding Assay of 63D3 with Monocyte-Macrophages from Other Species. Monocytes from various species were tested in the binding assay with human monocytes as a positive control. Guinea pig and hamster peritoneal exudate cells, rat and mouse peritoneal cells, and the mouse macrophage line J774 (33) were found to be negative.
Fluorescence-Activated Cell Sorter Analysis. A preparation of adherent human peripheral blood cells stained intensely with 63D3 antibody (Fig. 1 and Fig. 2 ). The population of cells that reacted with 63D3 antibody represented about 80% of the adherent cells. The control antibody stained a significant portion of this cellular population.
The data from which panel of Fig. 1 Top was derived is <10  <10  <10  <10  61D3  >80  <10  <10  <10  63D2  >80  <10  <10  <10  63D3  >80  <10  <10  <10   Exp. 2  Controlt  <10  <10  <10  ND  61D3  >80  <10  <10  ND  63D2   >80  <10  <10  ND  63D3  >80  <10  <10 ND Results shown were obtained after addition of rabbit anti-mouse IgG as described in Materials and Methods; without this step all reactions were negative. ND, not done. * Cells used in this experiment were from the same donor as those used in the immunization for the production of these hybridomas. t RPMI-1640 medium with 15% fetal calf serum used as a control.
shown in dot-plot analysis in Fig. 2 ; a large proportion of the cells were intensely stained by the 63D3 antibody. Additional information not obvious from Fig. 1 can be gleaned from the dot-plot-the A22B7 control stained with low intensity a large number of cells of varying sizes whereas 63D3 brightly stains a population of large cells not stained with the control. A highly purified population of human peripheral blood T cells was completely unreactive with 63D3 (Fig. 3) . The preparation of T cells shown in Fig. 3 was prepared by both nylon wool and erythrocyte resetting. However, the same result was obtained by rosetting as the sole means of purification. In other experiments, a highly purified population of B cells was unreactive with 63D3 by cell-sorter analysis (data not shown).
Structure of a Monocyte Cell Surface Antigen. The results of the immunoprecipitation analysis of biosynthetically labeled human monocytes reacting with the 63D3 antibody are shown in Fig. 4 . In this 5% NaDodSO4/polyacrylamide gel, the molecular weight of the reduced molecule was about 200,000. Precipitates run without reduction gave essentially the same results, and identical results were obtained with an additional monocyte-specific antibody, 63D2 (not shown). When freeze-thawing was used as a means of releasing cell surface molecules, a major band of identical molecular weight was obtained by fluorography. tigen one of the largest cell surface determinants described to date.
Our conclusions concerning the specificity of these antibodies must be tempered by the nature of the cell preparations studied. However, as shown in Fig. 3 , highly purified human peripheral blood T cells, prepared by resetting followed by filtration through nylon wool, were negative by fluorescence-activated cell sorter analysis with antibody 63D3. This finding supports the conclusion, initially based on binding and cytotoxicity assays, that this antibody does not react with T lymphocytes.
Adherent peripheral blood cells are usually about 70-80% monocytes and are frequently contaminated by some B and T lymphocytes and null cells. In Fig. 1 Top, a small (15%) population of adherent cells appears to be negative with both 63D3 and the control. Thus, either a small population of monocytes Reduction did not affect the apparent molecular weight.
is negative with 63D3 or, more likely, these unstained cells are lymphocytes contaminating the adherent cell pool. The specificity of these antibodies was tested by an indirect binding assay, by cytotoxicity assays, and by analysis on the fluorescence-activated cell sorter. Generally, comparable results were obtained. Adherent human peripheral blood mononuclear cells were strongly positive in all three test systems. Normal human granulocytes were weakly but consistently positive by the binding assay and by cell-sorter analysis but unreactive by cytotoxicity. The indirect binding assay could not have distinguished a minor contamination of the granulocyte population with a few peripheral blood monocytes. The weak and uniform staining of granulocytes in the cell-sorter analysis (Fig. 1 Middle) and the weak reactivity with cells from three patients with acute granulocytic leukemia in the binding assay suggests that this antigen is present, although in much lower density, on granulocytes.
Using a rat anti-mouse monoclonal antibody against macrophages, Springer et al. (13) observed weak reactivity with granulocytes similar to that obtained in the present experiments. In contrast, the monoclonal antibody OKM1 described by Breard et al. (14) showed granulocytes to be highly labeled. Taken together, these results support the previous conclusion that granulocytes and monocytes are related and probably share a common origin. The HL-60 cell line, which was negative by our analysis, might prove interesting in this regard because it can be induced to differentiate along monocytic or granulocytic lines, depending on the stimulus (22) .
As shown in Table 2 , most cell populations were negative in the binding assay. The human histiocytic lymphoma U937, which has many characteristics of a monocyte-like cell line and is known to develop additional properties associated with macrophages upon stimulation with lymphokines, did not react with 63D3. The lack of reactivity with endothelial cells argues that the antigen recognized by 63D3 is different from that described by Moraes and Stastny (22) who showed that some alloantibodies to human monocytes crossreact with human endothelial cells.
The molecule recognized by two of the three monoclonal antibodies produced in the present study is a cell surface protein with a molecular weight of 200,000. Mac-i, a macrophage differentiation antigen described by Springer et al. (13) , was a two-chain molecule which on reduction resulted in two polypeptides of molecular weights 190,000 and 105,000. Although the cellular distribution of the two antigens is comparable, their immunochemical analysis shows little similarity.
The three monoclonal anti-monocyte antibodies described herein are siiilar in many of their reactivity patterns to OKM1, recently reported by Breard et al. (14) and Reinherz et al. (34) . However, a striking difference is the reactivity of OKM1 with about 13% of human peripheral blood T lymphocytes (14) , especially those of the T-y type (34) . In our experiments, 63D3 reacted with less than 1/1000 cells of the T cell population.
Chemical characterization of the antigen recognized by OKM1 should clarify the relationship between these antibodies. The present communication provides the initial characterization of three monoclonal reagents which react with determinants present primarily on human peripheral blood monocytes. These reagents should prove useful in the clinical definition of various disorders of monocyte differentiation, in studies of monocyte function, and in the elucidation of the genetics and the structure of monocyte cell surface antigens.
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